Zolmitriptan-Mepha oro, Schmelztabletten - 3 Tablette(n) Swissmedic Key 61067007 Registration Holder Mepha Pharma AG Name Zolmitriptan-Mepha oro, Schmelztabletten Date of registration 27.05.2011 Introduction of Sequence 27.05.2011 ATC-Classification Zolmitriptan (N02CC03) Revision date WHO WHO-DDD Valid until 31.03.2025 Index Therapeuticus (BSV) 02.05.10. Show package size 3 Tablette(n) Index Therapeuticus (Swissmedic) 02.05.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price 10.14 Deductible k.A. Consumer price 27.45 Feedback FB Daily cost GTIN 7680610670072 Medication Code Synthetika Pharmacode 5417006 Disponibility
Composition zolmitriptanum 2.5 mg, silica colloidalis anhydrica, lactosum monohydricum 17 mg, maydis amylum, mannitolum, carmellosum natricum conexum, acidum citricum, natrii hydrogenocarbonas, magnesii stearas, aromatica (Orange) cum saccharum 1 mg, aspartamum 2 mg, pro compresso corresp. natrium 2.18 mg. Packungsbestandteile Galenic Form Melting tablets Active Agent Dose Zolmitriptan 2.5 mg
BAG: Active Agent Dose Zolmitriptan 2.5 mg
Inactive agents Dose Citric Acid Aromatica (Orange) cum Saccharum 1 mg Aspartame 2 mg Carmellosum Natricum Conexum Lactose Monohydrate 17 mg Magnesii Stearas Mannitol Maydis Amylum Sodium Hydrogen Carbonate Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 04.04.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :